Read more from the original source:
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
Category Archives: Global News Feed
PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and…
Galapagos and NovAliX enter into an integrated drug discovery collaboration
Sanofi: Information concerning the total number of voting rights and shares – December 2022
First Wave BioPharma Announces Adjournment of Special Meeting
View original post here:
First Wave BioPharma Announces Adjournment of Special Meeting
Revive Therapeutics Announces Publication Showing Bucillamine’s Potential Impact on COVID-19 Omicron Variants
Derm-Biome Pharmaceuticals’ Multi-Target Topical Drug Produces Positive Results in Preclinical Study in Acne
Revolution Medicines to Regain Global Rights to RMC-4630 following Sanofi’s Termination of SHP2 Inhibitor Development and Commercialization…
Assertio Holdings, Inc. Announces FDA Orange Book Listing for New Sympazan® Oral Film Patent
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
Update: Growcentia appoints Darrin Paschal as new chief commercial officer
Orion Corporation: Acquisition of Own Shares 04.11.2022
Vaxart to Present at World Vaccine Congress Europe 2022 on October 13
Read the rest here:
Vaxart to Present at World Vaccine Congress Europe 2022 on October 13
argenx Reports Third Quarter 2022 Financial Results and Provides Business Update
Originally posted here:
argenx Reports Third Quarter 2022 Financial Results and Provides Business Update
AB Science today reports its revenues for the first half of 2022 and provides an update on its activities
Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
See the original post:
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)